NLS Pharmaceutics AG (NLSPW) — Defensive Interval Ratio
NLS Pharmaceutics AG (NLSPW) has a Defensive Interval Ratio of 135 days as of September 2025. Defensive assets of $536.69K (cash $-, short-term investments $-, receivables $536.69K) cover 135 days of daily cash needs of $3.99K/day. Check how tangible is NLS Pharmaceutics AG's equity to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
NLS Pharmaceutics AG Defensive Interval Ratio (2018–2024)
This chart shows how NLS Pharmaceutics AG's Defensive Interval Ratio has evolved across 7 annual periods from 2018 to 2024. As of September 2025, the ratio stands at 135 days, meaning defensive assets of $536.69K can fund 135 days of operations without new revenue. Also explore how fast is NLS Pharmaceutics AG growing its equity to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for NLS Pharmaceutics AG (2018–2024)
The table below presents the year-by-year Defensive Interval Ratio for NLS Pharmaceutics AG from 2018 to 2024, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see NLS Pharmaceutics AG stock valuation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 177 days | $400.00K | $2.27K/day | $- | $- | ▲ +176 days |
| 2023 | 0 days | $10.66K | $21.70K/day | $- | $- | ▼ -4 days |
| 2022 | 4 days | $41.24K | $9.20K/day | $- | $- | ▼ -1 days |
| 2021 | 6 days | $38.55K | $6.58K/day | $- | $- | ▲ +3 days |
| 2020 | 3 days | $61.21K | $19.74K/day | $- | $- | ▼ -4 days |
| 2019 | 7 days | $75.39K | $11.06K/day | $- | $- | ▲ +1 days |
| 2018 | 6 days | $36.89K | $6.62K/day | $- | $- | — |